Mycenax Biotech (4726) — Cash Flow Quality Index

Latest as of March 2022: 3.23x

Mycenax Biotech (4726) has a Cash Flow Quality Index of 3.23x as of March 2022. Operating cash flow of NT$59.07 Million exceeds net income of NT$18.31 Million, indicating high earnings quality where cash backs reported profits. Also explore 4726 current and non-current assets for the complete picture of this company's asset base.

Cash Flow Quality Index

3.23x
Operating CF / Net Income

Operating Cash Flow

NT$59.07 Million
TWD

Net Income

NT$18.31 Million
TWD

Data as of

Mar 2022
Most recent filing

Mycenax Biotech Cash Flow Quality Index (2020–2020)

Historical Cash Flow Quality Index for Mycenax Biotech across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Mycenax Biotech (4726) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Mycenax Biotech (2020–2020)

Year-by-year earnings quality comparison for Mycenax Biotech. For live market cap and the full company financial profile, see Mycenax Biotech stock valuation.

Year Quality Index Operating CF (TWD) Net Income YoY Change
2020 5.63x NT$174.17 Million NT$30.95 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.